[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Granulomatosis with Polyangiitis Drug Sales Market Report 2018

February 2018 | 104 pages | ID: GC4C62A1933EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Granulomatosis with Polyangiitis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Granulomatosis with Polyangiitis Drug for these regions, from 2013 to 2025 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Granulomatosis with Polyangiitis Drug market competition by top manufacturers/players, with Granulomatosis with Polyangiitis Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bionovis SA
  • Bristol-Myers Squibb Company
  • ChemoCentryx Inc
  • Coherus BioSciences Inc
  • Genor BioPharma Co Ltd
  • GlaxoSmithKline Plc
  • Iltoo Pharma
  • Panacea Biotec Ltd
  • Sandoz International GmbH
  • The International Biotechnology Center (IBC) Generium
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Benralizumab
  • Avacopan
  • Rituximab Biosimilar
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Granulomatosis with Polyangiitis Drug Sales Market Report 2018

1 GRANULOMATOSIS WITH POLYANGIITIS DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Granulomatosis with Polyangiitis Drug
1.2 Classification of Granulomatosis with Polyangiitis Drug by Product Category
  1.2.1 Global Granulomatosis with Polyangiitis Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Granulomatosis with Polyangiitis Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Benralizumab
  1.2.4 Avacopan
  1.2.5 Rituximab Biosimilar
  1.2.6 Others
1.3 Global Granulomatosis with Polyangiitis Drug Market by Application/End Users
  1.3.1 Global Granulomatosis with Polyangiitis Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Global Granulomatosis with Polyangiitis Drug Market by Region
  1.4.1 Global Granulomatosis with Polyangiitis Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Granulomatosis with Polyangiitis Drug Status and Prospect (2013-2025)
  1.4.3 China Granulomatosis with Polyangiitis Drug Status and Prospect (2013-2025)
  1.4.4 Europe Granulomatosis with Polyangiitis Drug Status and Prospect (2013-2025)
  1.4.5 Japan Granulomatosis with Polyangiitis Drug Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Granulomatosis with Polyangiitis Drug Status and Prospect (2013-2025)
  1.4.7 India Granulomatosis with Polyangiitis Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Granulomatosis with Polyangiitis Drug (2013-2025)
  1.5.1 Global Granulomatosis with Polyangiitis Drug Sales and Growth Rate (2013-2025)
  1.5.2 Global Granulomatosis with Polyangiitis Drug Revenue and Growth Rate (2013-2025)

2 GLOBAL GRANULOMATOSIS WITH POLYANGIITIS DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Granulomatosis with Polyangiitis Drug Market Competition by Players/Suppliers
  2.1.1 Global Granulomatosis with Polyangiitis Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Granulomatosis with Polyangiitis Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Granulomatosis with Polyangiitis Drug (Volume and Value) by Type
  2.2.1 Global Granulomatosis with Polyangiitis Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Global Granulomatosis with Polyangiitis Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Granulomatosis with Polyangiitis Drug (Volume and Value) by Region
  2.3.1 Global Granulomatosis with Polyangiitis Drug Sales and Market Share by Region (2013-2018)
  2.3.2 Global Granulomatosis with Polyangiitis Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Granulomatosis with Polyangiitis Drug (Volume) by Application

3 UNITED STATES GRANULOMATOSIS WITH POLYANGIITIS DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Granulomatosis with Polyangiitis Drug Sales and Value (2013-2018)
  3.1.1 United States Granulomatosis with Polyangiitis Drug Sales and Growth Rate (2013-2018)
  3.1.2 United States Granulomatosis with Polyangiitis Drug Revenue and Growth Rate (2013-2018)
  3.1.3 United States Granulomatosis with Polyangiitis Drug Sales Price Trend (2013-2018)
3.2 United States Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Application (2013-2018)

4 CHINA GRANULOMATOSIS WITH POLYANGIITIS DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Granulomatosis with Polyangiitis Drug Sales and Value (2013-2018)
  4.1.1 China Granulomatosis with Polyangiitis Drug Sales and Growth Rate (2013-2018)
  4.1.2 China Granulomatosis with Polyangiitis Drug Revenue and Growth Rate (2013-2018)
  4.1.3 China Granulomatosis with Polyangiitis Drug Sales Price Trend (2013-2018)
4.2 China Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Players (2013-2018)
4.3 China Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Type (2013-2018)
4.4 China Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Application (2013-2018)

5 EUROPE GRANULOMATOSIS WITH POLYANGIITIS DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Granulomatosis with Polyangiitis Drug Sales and Value (2013-2018)
  5.1.1 Europe Granulomatosis with Polyangiitis Drug Sales and Growth Rate (2013-2018)
  5.1.2 Europe Granulomatosis with Polyangiitis Drug Revenue and Growth Rate (2013-2018)
  5.1.3 Europe Granulomatosis with Polyangiitis Drug Sales Price Trend (2013-2018)
5.2 Europe Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Application (2013-2018)

6 JAPAN GRANULOMATOSIS WITH POLYANGIITIS DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Granulomatosis with Polyangiitis Drug Sales and Value (2013-2018)
  6.1.1 Japan Granulomatosis with Polyangiitis Drug Sales and Growth Rate (2013-2018)
  6.1.2 Japan Granulomatosis with Polyangiitis Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Granulomatosis with Polyangiitis Drug Sales Price Trend (2013-2018)
6.2 Japan Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA GRANULOMATOSIS WITH POLYANGIITIS DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Granulomatosis with Polyangiitis Drug Sales and Value (2013-2018)
  7.1.1 Southeast Asia Granulomatosis with Polyangiitis Drug Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Granulomatosis with Polyangiitis Drug Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Granulomatosis with Polyangiitis Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Application (2013-2018)

8 INDIA GRANULOMATOSIS WITH POLYANGIITIS DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Granulomatosis with Polyangiitis Drug Sales and Value (2013-2018)
  8.1.1 India Granulomatosis with Polyangiitis Drug Sales and Growth Rate (2013-2018)
  8.1.2 India Granulomatosis with Polyangiitis Drug Revenue and Growth Rate (2013-2018)
  8.1.3 India Granulomatosis with Polyangiitis Drug Sales Price Trend (2013-2018)
8.2 India Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Granulomatosis with Polyangiitis Drug Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL GRANULOMATOSIS WITH POLYANGIITIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Bionovis SA
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Bionovis SA Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Bristol-Myers Squibb Company
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 ChemoCentryx Inc
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Coherus BioSciences Inc
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Genor BioPharma Co Ltd
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 GlaxoSmithKline Plc
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Iltoo Pharma
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Iltoo Pharma Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Panacea Biotec Ltd
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Sandoz International GmbH
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Sandoz International GmbH Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 The International Biotechnology Center (IBC) Generium
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Granulomatosis with Polyangiitis Drug Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview

10 GRANULOMATOSIS WITH POLYANGIITIS DRUG MAUFACTURING COST ANALYSIS

10.1 Granulomatosis with Polyangiitis Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Granulomatosis with Polyangiitis Drug
10.3 Manufacturing Process Analysis of Granulomatosis with Polyangiitis Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Granulomatosis with Polyangiitis Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Granulomatosis with Polyangiitis Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL GRANULOMATOSIS WITH POLYANGIITIS DRUG MARKET FORECAST (2018-2025)

14.1 Global Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Granulomatosis with Polyangiitis Drug Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Granulomatosis with Polyangiitis Drug Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Granulomatosis with Polyangiitis Drug Price and Trend Forecast (2018-2025)
14.2 Global Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Granulomatosis with Polyangiitis Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Granulomatosis with Polyangiitis Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 China Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 Europe Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Granulomatosis with Polyangiitis Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Granulomatosis with Polyangiitis Drug Sales Forecast by Type (2018-2025)
  14.3.2 Global Granulomatosis with Polyangiitis Drug Revenue Forecast by Type (2018-2025)
  14.3.3 Global Granulomatosis with Polyangiitis Drug Price Forecast by Type (2018-2025)
14.4 Global Granulomatosis with Polyangiitis Drug Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Granulomatosis with Polyangiitis Drug
Figure Global Granulomatosis with Polyangiitis Drug Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Benralizumab Product Picture
Figure Avacopan Product Picture
Figure Rituximab Biosimilar Product Picture
Figure Others Product Picture
Figure Global Granulomatosis with Polyangiitis Drug Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Granulomatosis with Polyangiitis Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Granulomatosis with Polyangiitis Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Granulomatosis with Polyangiitis Drug Sales Share by Players/Suppliers
Figure 2017 Granulomatosis with Polyangiitis Drug Sales Share by Players/Suppliers
Figure Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Granulomatosis with Polyangiitis Drug Revenue Share by Players
Table 2017 Global Granulomatosis with Polyangiitis Drug Revenue Share by Players
Table Global Granulomatosis with Polyangiitis Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Granulomatosis with Polyangiitis Drug by Type (2013-2018)
Figure Global Granulomatosis with Polyangiitis Drug Sales Growth Rate by Type (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Granulomatosis with Polyangiitis Drug by Type (2013-2018)
Figure Global Granulomatosis with Polyangiitis Drug Revenue Growth Rate by Type (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Granulomatosis with Polyangiitis Drug by Region (2013-2018)
Figure Global Granulomatosis with Polyangiitis Drug Sales Growth Rate by Region in 2017
Table Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Granulomatosis with Polyangiitis Drug by Region (2013-2018)
Figure Global Granulomatosis with Polyangiitis Drug Revenue Growth Rate by Region in 2017
Table Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Granulomatosis with Polyangiitis Drug by Region (2013-2018)
Figure Global Granulomatosis with Polyangiitis Drug Revenue Market Share by Region in 2017
Table Global Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Granulomatosis with Polyangiitis Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Granulomatosis with Polyangiitis Drug by Application (2013-2018)
Figure Global Granulomatosis with Polyangiitis Drug Sales Market Share by Application (2013-2018)
Figure United States Granulomatosis with Polyangiitis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Granulomatosis with Polyangiitis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Players (2013-2018)
Table United States Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players in 2017
Table United States Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table United States Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type in 2017
Table United States Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Application (2013-2018)
Table United States Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application in 2017
Figure China Granulomatosis with Polyangiitis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Granulomatosis with Polyangiitis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Players (2013-2018)
Table China Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players (2013-2018)
Figure China Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players in 2017
Table China Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type (2013-2018)
Figure China Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type in 2017
Table China Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Application (2013-2018)
Table China Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application (2013-2018)
Figure China Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application in 2017
Figure Europe Granulomatosis with Polyangiitis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Granulomatosis with Polyangiitis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players in 2017
Table Europe Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type in 2017
Table Europe Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application in 2017
Figure Japan Granulomatosis with Polyangiitis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Granulomatosis with Polyangiitis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players in 2017
Table Japan Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type in 2017
Table Japan Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application in 2017
Figure India Granulomatosis with Polyangiitis Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Granulomatosis with Polyangiitis Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Players (2013-2018)
Table India Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players (2013-2018)
Figure India Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Players in 2017
Table India Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type (2013-2018)
Figure India Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Type in 2017
Table India Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application (2013-2018)
Figure India Granulomatosis with Polyangiitis Drug Sales Volume Market Share by Application in 2017
Table Bionovis SA Basic Information List
Table Bionovis SA Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bionovis SA Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure Bionovis SA Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018)
Figure Bionovis SA Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table ChemoCentryx Inc Basic Information List
Table ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018
Figure ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table Coherus BioSciences Inc Basic Information List
Table Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018)
Figure Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table Genor BioPharma Co Ltd Basic Information List
Table Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018)
Figure Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018
Figure GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table Iltoo Pharma Basic Information List
Table Iltoo Pharma Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Iltoo Pharma Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure Iltoo Pharma Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018)
Figure Iltoo Pharma Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table Panacea Biotec Ltd Basic Information List
Table Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018
Figure Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table Sandoz International GmbH Basic Information List
Table Sandoz International GmbH Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sandoz International GmbH Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure Sandoz International GmbH Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018)
Figure Sandoz International GmbH Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table The International Biotechnology Center (IBC) Generium Basic Information List
Table The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Sales Growth Rate (2013-2018)
Figure The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Sales Global Market Share (2013-2018)
Figure The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Granulomatosis with Polyangiitis Drug
Figure Manufacturing Process Analysis of Granulomatosis with Polyangiitis Drug
Figure Granulomatosis with Polyangiitis Drug Industrial Chain Analysis
Table Raw Materials Sources of Granulomatosis with Polyangiitis Drug Major Players in 2017
Table Major Buyers of Granulomatosis with Polyangiitis Drug
Table Distributors/Traders List
Figure Global Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Granulomatosis with Polyangiitis Drug Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Granulomatosis with Polyangiitis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Granulomatosis with Polyangiitis Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Granulomatosis with Polyangiitis Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Granulomatosis with Polyangiitis Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Granulomatosis with Polyangiitis Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Granulomatosis with Polyangiitis Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Granulomatosis with Polyangiitis Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories